Author:
Liu Weiwei,Liu Chaoqun,Wang Hui,Xu Lijun,Zhou Jueyu,Li Sihua,Cheng Yu,Zhou Rui,Zhao Liang
Funder
Beijing Xisike Clinical Oncology Research Foundation
National Natural Science Foundation of China
Natural Science Foundation of Guangdong Province
Subject
Computer Science Applications,Genetics,Biochemistry,Structural Biology,Biophysics,Biotechnology
Reference176 articles.
1. The role of m6A epigenetic modification in the treatment of colorectal cancer immune checkpoint inhibitors;Tong;Front Immunol,2021
2. Radiolabelled polymeric materials for imaging and treatment of cancer: quo vadis?;Pant;Adv Healthc Mater,2017
3. Fundamental mechanisms of immune checkpoint blockade therapy;Wei;Cancer Discov,2018
4. Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy;Liu;Nat Commun,2017
5. T cell exclusion, immune privilege, and the tumor microenvironment;Joyce;Science,2015
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献